Healtheon/WebMD and Quintiles Transnational Receive Clearance To Complete Envoy Acquisition
PR NEWSWIRE - May 22, 2000 10:10
ATLANTA and RESEARCH TRIANGLE PARK, N.C., May 22, 2000 /PRNewswire via COMTEX/ -- Healtheon/WebMD Corporation (Nasdaq: HLTH) and Quintiles Transnational Corp. (Nasdaq: QTRN) today announced that they have received notification of the termination of the Hart-Scott-Rodino waiting period for Healtheon/WebMD to acquire Quintiles' electronic data interchange unit, ENVOY Corporation, as announced on Jan. 24, 2000.
As a result of the termination of the waiting period, Healtheon/WebMD and Quintiles intend to close the transaction in the near future.
About Healtheon/WebMD
Healtheon/WebMD is the first end-to-end Internet healthcare company connecting physicians and consumers to the entire healthcare industry. Healtheon/WebMD is using the Internet to facilitate a new system for the delivery of healthcare, resulting in a single, secure environment for all communications and transactions that will enable a more efficient and cost effective healthcare system. Healtheon/WebMD has its corporate headquarters in Atlanta and its technology headquarters in Silicon Valley. For more information visit webmd.com .
About Quintiles Transnational Corp.
Quintiles Transnational Corp. improves healthcare by bringing new medicines to patients faster and providing knowledge-rich medical and drug data to advance the quality and cost effectiveness of healthcare. Quintiles is the global market leader in helping pharmaceutical, biotechnology and medical device companies market and sell their products; and the company provides insightful market research solutions and strategic analyses to support healthcare decisions. Headquartered near Research Triangle Park, North Carolina, Quintiles employs a global workforce operating from offices in 31 countries. Quintiles Transnational is a member of the S&P 500, Fortune 1000 and Nasdaq 100. For more information visit www.quintiles.com .
Other than historical information set forth herein, information in this press release contains "forward-looking statements." These statements involve risks and uncertainties that could cause actual results to differ materially, including without limitation, completion of the transaction, the ability of Healtheon/WebMD's services to decrease costs and improve patient care, Healtheon/WebMD's limited operating history, continued growth in the use of the Internet, acceptance of the Internet as a secure medium over which to conduct transactions, the performance of Healtheon/WebMD and risks associated with its business, the volatility of the market for Healtheon/WebMD stock, actual operating performance, the ability to operate successfully in the alliance, and the ability to maintain large client contracts or to enter into new contracts. Additional factors that could cause actual results to differ materially are discussed in each of Healtheon/WebMD and Quintiles' recent filings with the Securities and Exchange Commission, including but not limited to S-1, S-3 and S-4 Registration Statements, Annual Reports on Form 10-K, Form 8-Ks, and other periodic reports, including Form 10-Qs. |
